A Genome-Wide Association Study Identifies Novel Susceptibility loci in Chronic Chagas Cardiomyopathy

Desiré Casares-Marfil1, Mariana Strauss2, Pau Bosch-Nicolau3

  • 1Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain.

Insights

Researchers identified a new genetic marker, rs2458298, linked to chronic Chagas cardiomyopathy in patients. This finding highlights host genetic factors in Chagas disease progression.

Area of Science:

  • Genetics
  • Infectious Diseases
  • Cardiology

Background:

  • Chagas disease, caused by Trypanosoma cruzi, is prevalent in Latin America.
  • Chronic Chagas cardiomyopathy is a severe complication of this neglected tropical disease.

Purpose of the Study:

  • To identify novel genetic loci associated with chronic Chagas cardiomyopathy.
  • To investigate genetic susceptibility in diverse Latin American populations.

Main Methods:

  • A genome-wide association study (GWAS) was conducted on 3413 Chagas disease patients from Colombia, Argentina, Bolivia, and Brazil.
  • Samples underwent genotyping, and results were meta-analyzed.
  • In silico analysis was performed to understand the functional impact of associated variants.

Main Results:

  • A novel genome-wide significant association (rs2458298) was found near the SAC3D1 gene (P-value = 3.27 × 10-08).
  • In silico analysis revealed functional links between the variant and cardiovascular-related genes (SNX15, BAFT2, FERMT3).

Conclusions:

  • Host genetic factors play a role in susceptibility to chronic Chagas cardiomyopathy.
  • This research contributes to understanding the genetic basis of this neglected disease.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.9K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
147
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
208
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
148
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
192
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
225